Tauromustine

This classification denotes a nitrosourea compound with the molecular formula C7H15ClN4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 511F69K76Y, chemically known as 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-n,n-dimethylethanesulfonamide but more generally known as tauromustine, which bears US NIH Compound Identifier 55456. European Medicines Agency schedules Tauromustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10838MIG. The term TAUROMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). TAUROMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule tauromustine under HS 29350090 and SITC 51580. As of Q4 2014, TAUROMUSTINE remains US FDA's Preferred Term for this commodity. Tauromustine bears US NLM identifiers UMLS ID C0044133 and NCI Concept Code C954. SMILES: CLCCN(N=O)C(=O)NCCS(=O)(=O)N(C)C.